The Frazier Growth Buyout team employs a thesis-driven, operating partner-centric investment model which capitalizes on long-term secular trends

28

years focused on healthcare

34

platform investments

100+

add-on acquisitions

$2.0B

equity invested

Strategy

Idea Generation
Alongside industry thought leaders and executives, the Growth Buyout team generates investment theses through its annual Montana CEO Summit, bi-annual retreats and proactive outreach to the broader healthcare ecosystem.
Investment Profile
The firm invests in profitable, lower middle-market healthcare companies with $5-50 million in EBITDA and makes equity commitments ranging from $30-350 million. Investments take the form of buyouts, recapitalizations and corporate carveouts.
Operating Partners
Leveraging its extensive network and human capital team, Frazier pairs proven executives with curated investment theses. This enables the pursuit of unique investment opportunities with the Operating Partner assuming an Executive Chairman or CEO role.
Executive Partner Team
Serving as a shared resource to the fund's portfolio companies, the Frazier Executive Partner team provides functional domain expertise in finance, human capital, legal, information technology and operations management.

Featured Portfolio Companies

Acquired by Tailwind Capital
Acquired by McKesson Corporation
Acquired by The Partners Group
View Full Portfolio

Growth Buyout News

Frazier Growth Buyout Team

Korn Ferry Cites Frazier's Human Capital Program as Best-in-class, along with KKR and Blackstone

Frazier Growth Buyout Team

Frazier Healthcare Partners Promotes Ben Magnano, Phil Zaorski; Adds Christina Miller Reszka to Team

The CORE Institute

CORE Sold to Audax, Linden

US Renal Care

Investor Group Buys U.S. Renal Care

View All News